A randomised trial of Dolutegravir (DTG)-based antiretroviral therapy vs. standard of care (SOC) in children with HIV infection starting first-line or switching to second-line ART

This is a randomised trial of dolutegravir (DTG)-based antiretroviral therapy vs. standard of care (SOC) in…

Investigation of specific immune response pattern in persons with active tuberculosis before and after receiving anti-tuberculous therapy

This study will evaluate the performance of the CD25/CD134 co-expression assay in detecting recall response to…

Disease Progression in HIV-HBV co-infection: Prospective longitudinal cohort

This is a long-term, international multi-site cohort to investigate the relationship between changes on liver biopsy,…

Depression, Vitamin D deficiency and osteoporosis among aging HIV infected and HIV uninfected population in Thailand

This study will assess the depression, vitamin D deficiency and osteoporosis among aging HIV-infected and HIV-uninfected…

An open-label, single arm study to evaluate the week 48 efficacy and safety of a two-drug regimen of Dolutegravir/Lamivudine (DTG/3TC) as a fixed dose combination (FDC), in antiretroviral therapy (ART)-naive HIV-1-infected adolescents, ≥ 12 to < 18 years of age who weigh at least 40 kg

Description: n/a

Prevalence of latent tuberculosis infection and implementation of Isoniazid prophylaxis in Thai prisons (1st year)

This study will assess the prevalence of latent TB infection (LTBI) in prisoners.

Anti-influenza hyperimmune intravenous immunoglobulin clinical outcome study

This is a randomized and double-blind study thatwill test whether giving IVIG to a larger number…

Study providing continued access to treatment with Darunavir (DRV)/Ritonavir (RTV) for adults coming from any of the three ongoing Tibotec-Sponsored studies with DRV

The primary objective of this trial is to continue the provision of DRV/rtv to adult patients…

A phase 3, randomized, open-label, controlled trial to investigate the efficacy and safety of UB-421 monotherapy as substitution for stable antiretroviral therapy in HIV-1 infected adults

Description: n/a

Program to help develop and propel HCV treatment for HIV/HCV co-infected patients using Peg IFN and Ribavirin through Thailand’s National Health Security Office (NHSO)

This study will assess the quality of life and side effects of treatment with Peg IFN…

A phase 3b/4 randomized open-label trial to compare Dolutegravir + pharmaco-enhanced Darunavir versus recommended standard of care antiretroviral regimens in patients with HIV infection who have failed recommended first line therapy

This is a phase IIIB/IV randomised open-label trial to compare dolutegravir + pharmaco-enhanced darunavir versus recommended…

Pharmacokinetics, efficacy, and safety of Rilpivirin in virologic suppressed HIV-infected Thai adolescents

This is an open-label, single arm study that will describe the immunologic and virologic outcomes (HIV…

A randomized, double-blinded, placebo-controlled trial comparing antiretroviral intensification with Maraviroc and Dolutegravir with no intensification or intensification with Dolutegravir alone for the treatment of cognitive impairment in HIV

Description: n/a

Impact of HIV infection on the population genomics of drug-resistant Mycobacterium tuberculosis: insights from macro-evolutionary analyses

This study will investigate the macroevolution of drug-resistant M. tuberculosis.

Effect of calcium and high-dose vitamin D supplementation on bone mineral density among prenatally HIV-infected children and adolescents (CAL-D)

This study is a multicenter, randomized, open-labeled, phase II clinical trial comparing the effect of a…